[1]
M. Mohamed, “INITIATING/SWITCHING TO INSULIN DEGLUDEC/INSULIN ASPART (IDEGASP) IN MALAYSIAN PATIENTS WITH TYPE 2 DIABETES IN REAL-WORLD SETTING”, J ASEAN Fed Endocr Soc, vol. 37, p. 25, Jul. 2022.